<DOC>
	<DOCNO>NCT01021930</DOCNO>
	<brief_summary>Diabetic patient prone diffuse rapidly progressive form atherosclerosis . Both clinical angiographic outcome follow percutaneous coronary intervention ( PCI ) poor patient DM compare without DM . Autopsy study show delay neointimal heal inadequate endothelialization persistent stent surface ﬁbrin deposition DES implantation DM patient . This might partially contribute high risk late stent thrombosis . YINYI Polymer-Free paclitaxel stent domestic new type stent bare metal base micro porous surface . However , limited data available vivo surface coverage stent implantation DM patient lack sensitive imaging modality . Optical coherence tomography ( OCT ) optical analogue intravascular ultrasound（IVUS）that allow high-resolution tomographic intravascular imaging . Furthermore , several study demonstrate feasibility OCT quantitatively evaluate surface coverage stent condition follow PCI . Therefore , aim study analyze surface coverage late malapposition two type DES implantation DM patient compare non-DM patient use OCT IVUS .</brief_summary>
	<brief_title>Comparison Diabetes Mellitus Non-diabetes Mellitus Patients DES Surface COVERage OCT</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>General Inclusion Criteria： 1 . Age : 1875Y 2 . Patients diagnose type 2 DM nonDM . Angiographic Inclusion Criteria： 1 . Patients consider eligible two significant ( &gt; 70 % ) angiographic stenosis lesion different native coronary vessel CAG . 2 . Each target de novo lesion treat 12 stent . 3 . Reference vessel diameter 2.5 4.0 mm . General Exclusion Criteria： 1 . STsegment elevation myocardial infarction within 7 day prior index procedure . 2 . Life expectancy &lt; 12 month due another medical condition . 3 . Contraindication antiplatelet therapy history hypersensitivity sirolimus paclitaxel structurally related compound . 4 . Creatinine level 2.0mg/dL ESRD . 5 . Severe hepatic dysfunction ( 3 time normal reference value ) . 6 . Planned surgery procedure≤12 month postindex procedure . 7 . Known allergy stainless steel . 8 . Female childbearing potential positive pregnancy test within 7 day index procedure , lactating , intend become pregnant 12 month post index procedure . 9 . Patient clinically appropriate OCT evaluation opinion investigator . Angiographic Exclusion Criteria： 1 . Study lesion ostial location ( within 3.0 mm vessel origin ) . 2 . Study lesion involve arterial segment highly tortuous anatomy . 3 . Complex lesion morphology ( bifurcation need two stent technique , leave main lesion , chronic obstructive occlusion , severe thrombus , heavy calcification ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Optical coherence tomography</keyword>
	<keyword>Drug elute stent</keyword>
	<keyword>Coronary heart disease</keyword>
	<keyword>Diabetes mellitus</keyword>
</DOC>